Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$98.98 - $115.74 $105,215 - $123,031
1,063 Added 1.88%
57,564 $6.66 Million
Q2 2023

Jul 19, 2023

BUY
$96.34 - $112.38 $590,178 - $688,439
6,126 Added 12.16%
56,501 $5.81 Million
Q1 2023

May 12, 2023

BUY
$107.32 - $113.5 $2.8 Million - $2.97 Million
26,129 Added 107.77%
50,375 $5.5 Million
Q4 2022

Feb 10, 2023

SELL
$62.39 - $113.8 $4.88 Million - $8.9 Million
-78,193 Reduced 76.33%
24,246 $2.76 Million
Q3 2022

Nov 03, 2022

BUY
$58.92 - $84.67 $610,764 - $877,689
10,366 Added 11.26%
102,439 $6.34 Million
Q2 2022

Aug 09, 2022

BUY
$79.4 - $116.36 $1.68 Million - $2.46 Million
21,153 Added 29.83%
92,073 $7.34 Million
Q1 2022

May 09, 2022

BUY
$86.42 - $109.81 $2.53 Million - $3.21 Million
29,224 Added 70.09%
70,920 $7.46 Million
Q4 2021

Feb 10, 2022

BUY
$98.56 - $119.91 $766,304 - $932,300
7,775 Added 22.92%
41,696 $4.49 Million
Q3 2021

Nov 09, 2021

BUY
$91.91 - $110.37 $603,297 - $724,468
6,564 Added 23.99%
33,921 $3.72 Million
Q2 2021

Aug 05, 2021

SELL
$86.24 - $95.92 $1.14 Million - $1.27 Million
-13,206 Reduced 32.56%
27,357 $2.56 Million
Q1 2021

May 11, 2021

BUY
$71.83 - $95.48 $1.5 Million - $1.99 Million
20,822 Added 105.48%
40,563 $3.73 Million
Q4 2020

Feb 11, 2021

BUY
$67.0 - $84.39 $626,852 - $789,552
9,356 Added 90.09%
19,741 $1.44 Million
Q3 2020

Nov 02, 2020

BUY
$55.23 - $79.93 $228,873 - $331,229
4,144 Added 66.4%
10,385 $807,000
Q2 2020

Aug 11, 2020

BUY
$30.2 - $56.98 $188,478 - $355,612
6,241 New
6,241 $347,000
Q3 2019

Oct 28, 2019

SELL
$23.0 - $27.97 $11.9 Million - $14.5 Million
-518,157 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$22.81 - $28.48 $11.8 Million - $14.8 Million
518,157 New
518,157 $12.5 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.